True Wealth Design’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.6K Sell
40
-75
-65% -$31.7K ﹤0.01% 916
2026
Q1
$54.4K Buy
115
+3
+3% +$1.51K 0.02% 379
2025
Q4
$52.2K Buy
112
+3
+3% +$1.39K 0.02% 322
2025
Q3
$46.6K Buy
109
+70
+179% +$27.1K 0.01% 330
2025
Q2
$14.8K Buy
39
+22
+129% +$7.93K 0.01% 462
2025
Q1
$5.71K Buy
17
+10
+143% +$3.22K ﹤0.01% 647
2024
Q4
$1.95K Sell
7
-3
-30% -$1.05K ﹤0.01% 743
2024
Q3
$4.07K Sell
10
-2,828
-100% -$1.04M ﹤0.01% 612
2024
Q2
$912K Sell
2,838
-11
-0.4% -$3.57K 0.23% 42
2024
Q1
$950K Sell
2,849
-113
-4% -$34.5K 0.24% 45
2023
Q4
$802K Buy
+2,962
New +$732K 0.23% 68

Other funds holding HCA

True Wealth Design's HCA Position: Q2 2026 in Review

True Wealth Design reduced its HCA Healthcare (HCA) stake by 65% in Q2 2026, selling an estimated $31.7K and leaving 40 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #916.

True Wealth Design first reported a position in HCA in Q4 2023 and has held it in 11 quarters since. The position peaked at $950K in Q1 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • True Wealth Design held 40 shares of HCA Healthcare worth $15.6K as of Q2 2026.
  • True Wealth Design sold 75 HCA Healthcare shares in Q2 2026, an estimated $31.7K.
  • HCA Healthcare made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #916 holding.
  • True Wealth Design first reported a position in HCA Healthcare in Q4 2023 and has held it in 11 quarters since.
  • True Wealth Design's HCA Healthcare position peaked at $950K in Q1 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.